Supreme Court mifepristone case will affect millions. Don’t base ruling off junk science.

Access to safe and effective medications like mifepristone should be based on rigorous scientific research and the medical community consensus – not the fringe opinions of a few extremists.

Julia Kaye
Jan 31, 2024

Overturning Roe v. Wade was just the beginning.

In Idaho v. United States, the question is whether states can disregard longstanding federal protections and bar doctors from providing abortions to patients experiencing medical emergencies.

The second case, Alliance for Hippocratic Medicine v. Food and Drug Administration, targets access to mifepristone, a safe and effective medication used in most abortions in this country and for miscarriage management. Since its FDA approval a quarter century ago, mifepristone has been safely used by more than 5 million people.

Continued: https://www.usatoday.com/story/opinion/voices/2024/01/31/supreme-court-abortion-pill-mifepristone-junk-science/72370445007/

Fear and confusion over abortion access persists as SCOTUS takes its first post-Dobbs case

Mifepristone will likely remain legal but could prove much harder to access. Legal and pharmaceutical experts have said this case could have far-reaching implications on approval for medications beyond abortion drugs.

by KELCIE MOSELEY-MORRIS AND SOFIA RESNICK
DECEMBER 19, 2023

This year will end on a major cliffhanger for abortion access.

Last November, anti-abortion activists via a powerful conservative Christian law firm asked a federal court to effectively ban or widely restrict the abortion drug mifepristone. Finally on Wednesday, the U.S. Supreme Court agreed to take the case, making Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration the high court’s first abortion-related case since overturning the federal right to an abortion in June 2022.

Continued: https://www.thelundreport.org/content/fear-and-confusion-over-abortion-access-persists-scotus-takes-its-first-post-dobbs-case

USA – Judge James Ho’s Connections to the Anti-Abortion Movement

An extreme right-wing judge and former clerk for Clarence Thomas, James Ho has close ties to anti-abortion and dark money groups.

10/5/2023
by ANSEV DEMIRHAN and EVAN VORPAHL

In August, three judges on the U.S. Court of Appeals for the Fifth Circuit (which covers Texas, Louisiana and Mississippi) ruled that mifepristone—the most widely used abortifacient, and more commonly known as the abortion pill—could no longer be provided by mail. They imposed a new requirement that the medicine only be administered in the presence of a physician. They also limited the use of this drug to the first seven weeks of pregnancy, even though it is safe to use at least throughout the first 10 weeks.

The ruling did overturn a lower federal court edict from Judge Matthew Kacsmaryk—a Trump-appointed judge who failed to disclose to the U.S. Senate and the American people his recent anti-abortion writings—to revoke the FDA’s 23-year old approval of mifepristone as a safe drug for Americans seeking abortions.

Continued: https://msmagazine.com/2023/10/05/judge-james-ho-abortion/

Abortion Bans in the U.S. Created a Human Rights Crisis

With reproductive rights already stripped away in half the country, anti-abortion activists are suing the FDA to ban the abortion drug mifepristone.

Jennifer Kerns
Published Mar. 29, 2023

The Supreme Court’s decision to overturn the constitutional right to abortion created a human rights crisis in vast swaths of the country.

Twenty-four states have banned abortion or are likely to do so. Clinics in neighboring states are overwhelmed with demand for appointments. Most of the patients I care for at Trust Women clinic in Kansas describe making numerous phone calls and waiting weeks for an appointment. A few months ago, our clinic received over 16,000 phone calls for an appointment in just one day.

Continued: https://www.thedailybeast.com/abortion-bans-in-the-us-created-a-human-rights-crisis

29.03.2023

Commentary

Alliance for Hippocratic Medicine v. FDA

self-managed abortion

USA – Danco Moves to Intervene in Lawsuit Challenging FDA Approval of Mifeprex®

Danco Laboratories

NEW YORK, Jan. 13, 2023 /PRNewswire/ -- Today, Danco Laboratories (Danco) filed a motion to intervene in Alliance for Hippocratic Medicine v. FDA, a lawsuit in which several anti-abortion organizations and four individual physicians asked a federal court to immediately suspend FDA's approval of Mifeprex®. If the judge grants the plaintiffs' request, it may block the availability of Mifeprex® for medication abortion nationwide as early as mid-February. Prescribers across the United States may not be able to prescribe Mifeprex® to their patients, because the drug could not be sold or shipped to certified healthcare providers. The plaintiffs filed this suit in the U.S. District Court for the Northern District of Texas, Amarillo Division, on November 18, 2022.

At a time when people across the country are already struggling to obtain abortion care services, this lawsuit aims to compound and limit access to abortion even further through a blatant attempt to completely deny people access to medication abortion care in the U.S. The lawsuit is also a direct challenge to the FDA approval process for all pharmaceutical products. Danco joins this action to ensure that the FDA approval of Mifeprex® remains in force and people continue to have access to this safe and effective medication.

Continued: https://www.prnewswire.com/news-releases/danco-moves-to-intervene-in-lawsuit-challenging-fda-approval-of-mifeprex-301721772.html

13.01.2023